| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |